3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Multiple Myeloma
5
Squamous Cell Carcinoma of Head and Neck
2
Peripheral Nervous System Diseases
2
Oropharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Vomiting
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Myasthenia Gravis
1
Mucositis
1
Lymphoma, Follicular
1
Lymphedema
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esthesioneuroblastoma, Olfactory
1
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Acupuncture Therapy
×
Clear all
No trials found.